Cargando…
MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge
MUC1 glycoprotein is often found overexpressed and hypoglycosylated in tumor cells from numerous cancer types. Since its discovery MUC1 has been an attractive target for antitumor immunotherapy. Indeed, in vitro and in vivo experiments have shown T-cell-specific responses against MUC1 in an HLA-rest...
Autores principales: | Roulois, David, Grégoire, Marc, Fonteneau, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591236/ https://www.ncbi.nlm.nih.gov/pubmed/23509794 http://dx.doi.org/10.1155/2013/871936 |
Ejemplares similares
-
Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy
por: Lee, Ji Hee, et al.
Publicado: (2010) -
Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes
por: Kontani, K, et al.
Publicado: (2001) -
Induction of an Antigen-specific, CD1-restricted Cytotoxic T Lymphocyte Response In vivo
por: Lee, Delphine J., et al.
Publicado: (1998) -
The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins
Publicado: (1978) -
Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine
por: Roulois, David, et al.
Publicado: (2016)